AYLA

Ayala Pharmaceuticals Inc
0.503601
0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Ayala Pharmaceuticals Inc AYLA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.503601 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.503601 0.503601
more quote information »

Recent News

Date Time Source Heading
1/25/202316:54EDGARCurrent Report Filing (8-k)
1/24/202310:22EDGARStatement of Changes in Beneficial Ownership (4)
1/24/202306:07EDGARNotice of Effectiveness (effect)
1/24/202306:07EDGARNotice of Effectiveness (effect)
1/19/202315:52EDGARPost-effective Amendment to Registration Statement (pos Am)
1/19/202315:44EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
1/19/202315:33EDGARNotification Filed by National Security Exchange to Report..
1/13/202316:02EDGARCurrent Report Filing (8-k)
1/04/202317:04EDGARCurrent Report Filing (8-k)
11/23/202216:04EDGARCurrent Report Filing (8-k)
11/17/202216:36EDGARCurrent Report Filing (8-k)
11/04/202216:38EDGARFiling of Certain Prospectuses and Communications in..
11/03/202216:08EDGARQuarterly Report (10-q)
10/19/202217:11EDGARFiling of Certain Prospectuses and Communications in..
10/19/202217:07EDGARCurrent Report Filing (8-k)
10/11/202204:46TRMNH.C. Wainwright Reaffirms Their Buy Rating on Ayala..
10/11/202204:45TRMNNoble Financial Reaffirms Their Hold Rating on Ayala..
9/27/202210:11TRMNAyala Pharma (NASDAQ:AYLA) Bags fast Track Status for..
9/27/202208:58DJNAyala Pharmaceuticals Gets Fast-Track Designation for AL102..
9/19/202206:25TRMNH.C. Wainwright Sticks to Their Buy Rating for Ayala..
9/13/202208:05TRMNAyala Pharmaceuticals (AYLA) Receives a Buy from Noble..
9/12/202208:16EDGARCurrent Report Filing (8-k)
8/17/202208:05TRMNNoble Financial Keeps Their Buy Rating on Ayala..
8/16/202216:40APSQ2 Financial Results Send Micro Cap Soaring
8/15/202216:21EDGARQuarterly Report (10-q)
7/27/202208:25TRMNNoble Financial Thinks Ayala Pharmaceuticals’ Stock is Going..
7/26/202214:24TRMNAyala Pharmaceuticals Stock Nearly Triples on Desmoid Tumor..
7/25/202217:21EDGARWithdrawal of Registration Statement (rw)
7/05/202217:04EDGARCurrent Report Filing (8-k)
6/15/202216:16EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202216:16EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202216:15EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202216:17EDGARCurrent Report Filing (8-k)
5/19/202206:26TRMNH.C. Wainwright Reiterates a Buy Rating on Ayala..
5/17/202208:45TRMNNoble Financial Reaffirms Their Buy Rating on Ayala..
5/16/202216:31EDGARStatement of Changes in Beneficial Ownership (4)
5/16/202216:28EDGARQuarterly Report (10-q)
5/16/202216:23EDGARStatement of Changes in Beneficial Ownership (4)
5/16/202216:20EDGARStatement of Changes in Beneficial Ownership (4)
4/27/202216:04EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/30/202206:35TRMNAnalysts Conflicted on These Healthcare Names: Acelrx (ACRX)..
3/28/202216:40SEEKAyala Pharmaceuticals GAAP EPS of -$2.80, revenue of $3.5M
3/28/202213:32EDGARAnnual Report (10-k)
3/09/202206:24TRMNH.C. Wainwright Thinks Ayala Pharmaceuticals’ Stock is Going..
3/02/202206:36TRMNH.C. Wainwright Thinks Ayala Pharmaceuticals’ Stock is Going..
2/14/202217:29EDGARAmended Statement of Ownership (sc 13g/a)
2/04/202209:17EDGARSchedule 13g
1/31/202210:58EDGARAmended Statement of Ownership (sc 13g/a)